Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms, Second Primary × dostarlimab × 1 year × Clear all

Sponsor

Conditions

Neoplasms 14 Endometrial Neoplasms 11 Carcinoma, Non-Small-Cell Lung 10 Uterine Cervical Neoplasms 5 Neoplasm Metastasis 5 Breast Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Rectal Neoplasms 4 Ovarian Neoplasms 4 Colonic Neoplasms 4 Pancreatic Neoplasms 3 Melanoma 3 Head and Neck Neoplasms 3 Triple Negative Breast Neoplasms 2 Stomach Neoplasms 2 Osteosarcoma 2 Locally Advanced Rectal Cancer (LARC) 2 Colorectal Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Neuroendocrine 2 Carcinoma, Hepatocellular 2 Carcinoma 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Neoplasms 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Sarcoma 1 Rhabdomyosarcoma 1 Recurrence 1

Interventions

Varenicline 1 Tyrosine Kinase Inhibitors 1 Trastuzumab 1 Tobacco Use Cessation Devices 1 Registries 1 Probiotics 1 Patient Reported Outcome Measures 1 Nicotine Chewing Gum 1 Interviews as Topic 1 Cisplatin 1 Bupropion 1 Bleomycin 1 Anthracyclines 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡